Management of Elevated Hemoglobin

Initial Assessment and Diagnosis

A complete blood count with differential should be performed to assess other cell lines and rule out myeloproliferative disorders, and evaluate for secondary causes of erythrocytosis, such as chronic hypoxemia, smoking, and renal disease, according to the American College of Physicians 1
The American Society of Hematology recommends considering JAK2 V617F mutation testing to rule out polycythemia vera 1

The American Heart Association recommends phlebotomy as the first-line treatment for patients with hemoglobin >18.5 g/dL to reduce viscosity and thrombotic risk 1
Initial phlebotomy of 250-500 mL should be performed to rapidly reduce hemoglobin levels, with a target hemoglobin of <15 g/dL in men and <14 g/dL in women, as suggested by the American College of Cardiology 1

Phlebotomy remains the cornerstone of treatment, with a target hematocrit <45%, and low-dose aspirin (81-100 mg daily) should be initiated to reduce thrombotic risk, unless contraindicated, according to the National Comprehensive Cancer Network 1

Addressing the underlying cause, such as COPD, sleep apnea, or smoking cessation, is crucial, and phlebotomy should be considered for symptomatic patients or those with hemoglobin >18.5 g/dL, as recommended by the American Thoracic Society 1

The American Society of Clinical Oncology recommends avoiding erythropoiesis-stimulating agents (ESAs) as they can worsen erythrocytosis, and if ESAs are being used for another condition, they should be discontinued immediately 2, 3

Each 400 mL unit of packed red cells removed results in approximately 1.5 g/dL decrease in hemoglobin, according to the Journal of Hepatology 4
Erythropoiesis-stimulating agents (ESAs), such as epoetin alfa and darbepoetin alfa, must be discontinued immediately as they worsen erythrocytosis, as reported in Blood and the Journal of the National Comprehensive Cancer Network 5, 6
ESAs are used to increase hemoglobin in anemia, not decrease it, and their use is contraindicated in patients with elevated hemoglobin levels, as noted in the Journal of Hepatology 4, 7, 8, 9

In hereditary methemoglobinemia with compensatory polycythemia, phlebotomy is not recommended as higher erythrocyte mass allows normal tissue oxygenation, according to the American Journal of Hematology 10